📞 
— free, 24/7
— free, 24/7 — free, 24/7| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 0,5mg | 270 pills | €0.85 | €256.46 €230.81 Popular | |
| 0,5mg | 360 pills | €0.63 | €250.13 €225.11 Best Price | |
| 0,5mg | 180 pills | €1.08 | €216.88 €195.19 | |
| 0,5mg | 120 pills | €1.42 | €189.97 €170.97 | |
| 0,5mg | 90 pills | €1.62 | €163.05 €146.75 | |
| 0,5mg | 60 pills | €1.90 | €126.64 €113.97 |
Disclaimer: This information is intended for adults in Ireland and is not a substitute for professional medical advice. Always consult a healthcare professional before starting colchicine or changing a treatment plan.
Colchicine is a medication used to control certain inflammatory conditions. It belongs to the class of alkaloids derived from Colchicum autumnale and acts to reduce inflammation rather than to relieve pain alone. The active ingredient is colchicine, the chemical component that produces the therapeutic effects.
Colchicine is prescribed to help manage acute gout flares, which are sudden, intense episodes of joint swelling, warmth, and pain. It is also used in certain periodic fever syndromes and in some inflammatory heart conditions under medical supervision. The purpose is to shorten the duration of attacks and reduce the risk of future flares for specific conditions.
In routine practice, colchicine is taken by mouth in tablet form. It is generally prescribed by a doctor or specialist and may be provided by a community pharmacist after a consultation with a healthcare professional. The exact regimen depends on the condition being treated and individual health factors.
Note: The information provided here is not a substitute for the official patient information leaflet supplied with the medicine. The leaflet contains product-specific instructions, contraindications, and warnings. Always follow the directions given by a prescriber or pharmacist and check with a healthcare professional if any doubt arises.
Colchicine is used to treat gout flares, which present as sudden, severe joint pain often accompanied by swelling and redness. The pain can be most intense in the first hours after onset and may limit normal movement. The goal is to shorten the flare and reduce inflammation in the affected joint.
It is also employed as a prophylactic measure to prevent recurrent gout flares in some patients who begin urate-lowering therapy. In this role, colchicine helps to lessen the frequency of future attacks while the underlying uric acid balance is being adjusted.
Beyond gout, colchicine has established uses in familial Mediterranean fever (FMF), a hereditary inflammatory condition characterized by episodic fevers and abdominal, chest, or joint pain. It is sometimes used in the management of recurrent pericarditis (inflammation around the heart) under specialist guidance. These uses are dependent on confirmed diagnosis and clinical judgement.
In all cases, the decision to use colchicine is made by a clinician after considering the balance of benefits and risks for the individual patient. The information provided here is intended to support conversations with a healthcare professional. If uncertainty exists, consult the official leaflet or a pharmacist or doctor before starting treatment.
Colchicine acts at the level of the cells involved in inflammation. It interferes with the growth and movement of microtubules, which are structural components inside cells. This action reduces the ability of white blood cells to migrate to areas of inflammation.
As a result, the inflammatory response that causes joint swelling and pain during a gout flare is dampened. The overall effect is a decrease in the intensity and duration of the attack, rather than immediate pain relief alone.
Because the mechanism involves cellular processes, the therapeutic effect depends on proper dosing and timing under medical supervision. The potential for side effects and interactions is greater if the medication is not used exactly as prescribed. Always follow the instructions provided by a healthcare professional.
Where appropriate, the clinician may explain additional considerations about how colchicine interacts with other medications, foods, or underlying conditions. If questions arise about the mechanism, ask a pharmacist or doctor for clarification based on the individual health profile.
The exact dose and duration are determined by the treating clinician, taking into account the condition being treated, kidney and liver function, and other medicines. A prescription should be followed closely, and any adjustments should be made only under professional guidance. Do not change the dose without consulting a healthcare professional.
Colchicine tablets are typically swallowed with a full glass of water. They are generally taken at regular intervals as prescribed. In some regimens, a dose may be taken after meals to reduce stomach upset, but this depends on the prescribed plan and the patient’s tolerance.
It is important to use the medicine exactly as directed. Do not skip doses or double up to make up for a missed dose unless advised by a clinician. If a dose is missed, contact a healthcare professional for guidance rather than attempting to self-correct with extra dosing.
Patients should inform the prescriber about all medicines currently used, including non-prescription drugs and herbal products. Certain medicines can interact with colchicine and require dosage adjustments or alternative therapies. The pharmacist can provide personalised advice after a full medication review.
Colchicine should not be used in individuals with a known hypersensitivity to colchicine or any component of the tablet. A history of adverse reactions to this drug requires careful evaluation before considering treatment.
Severe kidney disease or severe liver disease increases the risk of serious adverse effects and may necessitate avoiding colchicine or using it only under strict specialist supervision. Renal or hepatic impairment requires careful dose adjustment and monitoring.
Concomitant use of certain medicines that strongly interact with colchicine can raise drug levels in the body and increase toxicity. Examples include some inhibitors of the enzyme pathways CYP3A4 and P-glycoprotein. The safety of combining colchicine with other medications should be assessed by a clinician.
Pregnancy and breastfeeding require careful consideration. Colchicine may be used only if potential benefits justify potential risks, and management should involve a clinician. Breastfeeding while using colchicine requires professional advice. Where uncertainty remains, the reader should consult the official leaflet or a healthcare professional.
Children and adolescents require specific dosing and clinical supervision. The safety and appropriateness of colchicine in younger patients should be determined by a clinician. If there is doubt, seek guidance from a doctor or pharmacist.
Several precautions help minimise the risk of adverse effects or drug interactions. The possibility of serious toxicity increases with higher doses, advanced age, or reduced organ function, including kidney or liver impairment. Regular medical review is advised during ongoing treatment.
Gastrointestinal symptoms such as persistent diarrhoea, vomiting, or abdominal pain may indicate intolerance or toxicity. Dehydration from excessive diarrhoea can worsen the condition and may necessitate urgent medical assessment. Seek medical help if these symptoms become severe or prolonged.
Muscle pain, tenderness, or weakness can occur and may indicate myopathy, especially when certain other medicines are used concurrently. Whistling or unusual sensations in the skin or joints, numbness, or tingling are less common but warrant medical review. Any new or worsening muscle symptoms should be reported promptly.
Blood tests may be used to monitor safety in some patients, particularly those on long-term therapy or with kidney or liver disease. The clinician may adjust the treatment based on test results and clinical response. Throughout treatment, report any signs of infection, unusual fatigue, or fever, as these could signal complications requiring attention.
Most people tolerate colchicine well when used as directed, but side effects can occur. The most common are gastrointestinal, including abdominal pain, diarrhoea, and nausea. These symptoms are usually temporary and may improve with continued treatment or following a dose adjustment.
Less commonly, individuals may experience vomiting, reduced appetite, or a transient rash. These effects should be discussed with a healthcare professional if they persist or cause concern.
Serious but rare adverse effects include significant muscle weakness or pain, severe dehydration due to diarrhoea, or signs of blood or fever changes suggesting a more serious reaction. Urgent medical evaluation is necessary if severe symptoms occur. The likelihood of serious events increases with improper dosing or interactions with other medicines.
Colchicine can interact with a range of other medicines, potentially increasing the risk of adverse effects. Interactions may be more likely in individuals with kidney or liver impairment, older adults, or when multiple medicines are used concurrently. A full medication review with a pharmacist or doctor is advised before starting therapy.
Key interaction categories include strong inhibitors of CYP3A4 or P-glycoprotein, which can raise colchicine levels in the body. Examples include certain antifungals, antibiotics, and some antiviral medications, among others. The clinician will assess the risk and determine if dose adjustments or alternative treatments are needed.
Additional interactions may occur with medicines that affect kidney function, as well as with certain statins, fibrates, or immune-modulating drugs. Alcohol consumption and herbal or vitamin supplements should be discussed with a healthcare professional, as some products may influence colchicine metabolism or toxicity risk.
Patients should inform the treating clinician about all medicines, including over‑the‑counter drugs and herbal products. If a new medicine is started while colchicine is being used, contact a healthcare professional to review potential interactions. Do not start or stop medicines without professional guidance.
Pregnancy introduces considerations about the safety of colchicine. The potential benefits must be weighed against possible risks to the fetus. Consultation with a obstetrician or a clinician experienced in medication use during pregnancy is essential prior to continuing or initiating therapy.
Colchicine can pass into breast milk. Breastfeeding while taking colchicine should be discussed with a healthcare professional, who can weigh infant exposure against maternal treatment needs. In some cases, alternative therapies or timing adjustments may be recommended.
In all cases, treatment decisions during pregnancy or lactation should be made by a clinician. If pregnancy is planned or suspected, or if breastfeeding is ongoing, seek guidance from a pharmacist or doctor to determine the safest approach. The official patient information leaflet should be reviewed for pregnancy and lactation-specific warnings.
Kidney function can influence the safety and dosing of colchicine. In the presence of kidney impairment, the clinician may adjust the dose or select an alternative treatment. A healthcare professional should review the suitability of colchicine in such cases before continuing therapy.
If a dose is missed, do not double the next dose unless explicitly advised by a clinician. Contact a healthcare professional for guidance on how to proceed, as timing and safety depend on the condition being treated and the treatment plan.
For an acute gout flare, some individuals notice improvement within the first day or two, while others may take longer. Time to response varies with the severity of the attack and individual factors. If there is no improvement or if symptoms worsen, medical advice should be sought promptly.
Alcohol use may influence overall health and the risk of dehydration during a flare. While moderate consumption may be permissible in some cases, discussions with a clinician are advised to tailor advice to the individual’s health status and treatment plan. Do not exceed recommended allowances and monitor for any adverse effects.
Long-term use is sometimes necessary for certain conditions under specialist supervision. Regular medical review is important to monitor for side effects, drug interactions, and the ongoing need for therapy. The clinician will determine whether continued treatment remains appropriate.
The duration of treatment depends on the condition being treated and the patient’s response. Some regimens are short-term, especially during an acute flare, while others may extend over weeks or months under supervision. Follow the clinician’s plan and report any concerns promptly.
Some medicines can be taken with colchicine under supervision, while others require dose adjustments or alternatives due to interaction risks. A full medication review with a pharmacist or clinician is advised before combining therapies. Always disclose all medicines to the treating professional.
Most side effects are manageable or reversible with dose adjustments or supportive care. Persistent or severe symptoms, especially muscle cramps, weakness, or dehydration, require medical evaluation. Do not ignore warning signs.
Pregnancy and breastfeeding require careful consideration. The decision to use colchicine during pregnancy or breastfeeding should involve a clinician who can weigh potential benefits against risks to the fetus or infant. Always discuss family planning and medication use with a healthcare professional.
Access to colchicine may vary by local rules and the specific health system. Depending on location in Ireland, a prescription may be required or may be available through a pharmacist under a guided pathway. Check with a pharmacist or doctor about the current local requirements before obtaining the medication.
Dietary supplements and herbal products can interact with colchicine or affect its metabolism. A conversation with a healthcare professional is advised before combining therapies. Report all supplements to the prescriber so that a safe plan can be maintained.
The official patient information leaflet supplied with the medicine contains detailed instructions, contraindications, warnings, and dose-specific information. This document is tailored to the exact brand and formulation being used and should be consulted regularly.
Healthcare providers, including general practitioners and hospital clinicians, can offer personalised guidance based on the patient’s health status and current medications. A pharmacist can also review potential drug interactions and provide practical advice on administration and storage.
In Ireland, additional information may be available from the Health Service Executive (HSE) resources and the Health Products Regulatory Authority (HPRA). If doubts persist after consulting the leaflet and a clinician, seek a face-to-face review to ensure safe and appropriate use.
14–21 days. Free from €171.67 .
5–9 days. €25.75
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
